Profile data is unavailable for this security.
About the company
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
- Revenue in USD (TTM)376.97m
- Net income in USD-8.32m
- Incorporated2022
- Employees1.50k
- LocationArtivion Inc1655 Roberts Boulevard N WKENNESAW 30144United StatesUSA
- Phone+1 (770) 419-3355
- Fax+1 (770) 426-0031
- Websitehttps://artivion.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Standard Biotools Inc | 136.30m | -164.66m | 746.02m | 534.00 | -- | 1.46 | -- | 5.47 | -0.9018 | -0.9018 | 0.6606 | 1.37 | 0.2561 | 2.25 | 5.73 | 255,243.50 | -22.29 | -28.17 | -26.55 | -33.60 | 46.67 | 51.58 | -87.05 | -74.85 | 3.53 | -- | 0.0974 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
| Alphatec Holdings Inc | 540.28m | -180.91m | 846.97m | 839.00 | -- | 50.40 | -- | 1.57 | -1.34 | -1.34 | 4.00 | 0.2847 | 0.7736 | 1.13 | 7.30 | 643,959.50 | -25.90 | -30.97 | -33.24 | -39.47 | 69.44 | 66.02 | -33.48 | -46.22 | 1.21 | -4.59 | 0.9273 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| Castle Biosciences Inc | 287.59m | -3.10m | 872.88m | 610.00 | -- | 2.06 | 87.40 | 3.04 | -0.1346 | -0.1346 | 10.45 | 15.30 | 0.6302 | 7.38 | 7.44 | 471,457.40 | -0.6791 | -9.43 | -0.7383 | -10.17 | 81.86 | 80.58 | -1.08 | -28.46 | 7.92 | -- | 0.0238 | -- | 60.38 | 57.35 | 14.41 | -- | 117.94 | -- |
| Embecta Corp | 1.12bn | 69.70m | 900.73m | 2.20k | 12.94 | -- | 8.32 | 0.805 | 1.21 | 1.21 | 19.36 | -13.24 | 0.8882 | 2.11 | 11.60 | 508,590.90 | 5.53 | -- | 7.91 | -- | 66.42 | -- | 6.23 | -- | 1.61 | 2.06 | 1.88 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Bioventus Inc | 536.89m | -41.96m | 959.54m | 1.03k | -- | 6.36 | -- | 1.79 | -0.6595 | -0.6595 | 8.48 | 1.86 | 0.6591 | 1.95 | 4.18 | 553,495.90 | -6.70 | -5.52 | -9.65 | -7.27 | 66.53 | 68.25 | -10.16 | -10.94 | 0.956 | 1.08 | 0.6697 | -- | 0.0445 | 9.93 | 6.91 | -- | 23.51 | -- |
| Figs Inc | 550.80m | 18.68m | 965.36m | 354.00 | 54.92 | 2.40 | 43.27 | 1.75 | 0.1029 | 0.1029 | 3.04 | 2.35 | 1.18 | 1.23 | 58.02 | 1,555,932.00 | 3.99 | -- | 4.65 | -- | 68.02 | -- | 3.39 | -- | 3.89 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
| Artivion Inc | 376.97m | -8.32m | 1.06bn | 1.50k | -- | 3.57 | 70.36 | 2.80 | -0.2076 | -0.2076 | 9.11 | 7.06 | 0.481 | 1.67 | 5.44 | 251,316.00 | -1.07 | -2.20 | -1.15 | -2.36 | 64.63 | 65.51 | -2.22 | -5.34 | 4.04 | 1.07 | 0.5177 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| Pulse Biosciences Inc | 0.00 | -44.02m | 1.10bn | 56.00 | -- | 36.59 | -- | -- | -0.7916 | -0.7916 | 0.00 | 0.4883 | 0.00 | -- | -- | 0.00 | -76.43 | -93.21 | -84.97 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
| Avanos Medical Inc | 682.40m | 7.00m | 1.11bn | 3.77k | 157.53 | 0.907 | 21.25 | 1.63 | 0.1532 | 0.1671 | 14.71 | 26.62 | 0.4105 | 1.93 | 5.20 | 180,960.00 | 0.4211 | -0.6527 | 0.4737 | -0.7338 | 55.82 | 54.45 | 1.03 | -1.60 | 1.49 | 7.06 | 0.1253 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Establishment Labs Holdings Inc | 151.35m | -83.20m | 1.19bn | 857.00 | -- | 26.35 | -- | 7.84 | -3.11 | -3.11 | 5.62 | 1.61 | 0.5307 | 0.8525 | 2.72 | 166,685.00 | -29.17 | -33.22 | -34.29 | -41.12 | 66.04 | 64.73 | -54.97 | -43.19 | 2.91 | -20.68 | 0.8114 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| BioLife Solutions Inc | 121.17m | -53.87m | 1.19bn | 409.00 | -- | 3.70 | -- | 9.81 | -1.21 | -1.64 | 2.69 | 6.97 | 0.2999 | 1.99 | 5.39 | 296,254.30 | -13.33 | -13.76 | -14.60 | -15.04 | 41.27 | 36.76 | -44.46 | -42.99 | 1.81 | -5.98 | 0.0651 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Owens & Minor, Inc. | 10.53bn | -42.44m | 1.22bn | 13.70k | -- | 1.42 | 5.10 | 0.1163 | -0.5532 | -0.5532 | 137.98 | 11.17 | 1.99 | 6.95 | 15.78 | 768,728.30 | -0.8014 | 1.32 | -1.25 | 2.07 | 20.78 | 16.48 | -0.403 | 0.5614 | 0.5141 | 2.11 | 0.7076 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Inmode Ltd | 416.63m | 149.20m | 1.33bn | 581.00 | 10.05 | 1.92 | 8.87 | 3.19 | 1.73 | 1.73 | 4.84 | 9.09 | 0.5228 | 1.62 | 11.78 | 717,084.30 | 18.72 | 31.32 | 20.79 | 35.64 | 82.27 | 84.46 | 35.81 | 39.65 | 8.09 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| Integra Lifesciences Holdings Corp | 1.57bn | 23.65m | 1.35bn | 3.95k | 58.76 | 0.8799 | 8.85 | 0.8617 | 0.2961 | 0.2961 | 20.02 | 19.77 | 0.399 | 1.55 | 5.81 | 396,986.10 | 0.6023 | 3.33 | 0.6618 | 3.68 | 61.54 | 63.67 | 1.51 | 7.99 | 2.10 | 5.88 | 0.5433 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
| AtriCure Inc | 429.95m | -40.12m | 1.41bn | 1.20k | -- | 3.06 | -- | 3.29 | -0.8606 | -0.8606 | 9.22 | 9.49 | 0.7217 | 1.68 | 8.27 | 358,294.20 | -6.73 | -3.72 | -7.58 | -4.10 | 74.84 | 74.36 | -9.33 | -7.64 | 2.93 | -11.79 | 0.12 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
Data as of Sep 21 2024. Currency figures normalised to Artivion Inc's reporting currency: US Dollar USD
58.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 6.14m | 14.70% |
| Macquarie Investment Management Business Trustas of 30 Jun 2024 | 2.81m | 6.73% |
| Perceptive Advisors LLCas of 31 Mar 2024 | 2.67m | 6.40% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 2.60m | 6.24% |
| Juniper Investment Co. LLCas of 31 Mar 2024 | 2.10m | 5.03% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 2.03m | 4.85% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.59m | 3.82% |
| Dimensional Fund Advisors LPas of 30 Jun 2024 | 1.59m | 3.81% |
| Wellington Management Co. LLPas of 31 Mar 2024 | 1.46m | 3.51% |
| GW&K Investment Management LLCas of 31 Mar 2024 | 1.23m | 2.94% |
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
